{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T13:48:35Z","timestamp":1793713715699,"version":"4.6.1"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021202","name":"Alliance de recherche num\u00e9rique du Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["376288"],"award-info":[{"award-number":["376288"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["435710"],"award-info":[{"award-number":["435710"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["5026"],"award-info":[{"award-number":["5026"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["DNA Repair"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.dnarep.2022.103433","type":"journal-article","created":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T20:10:04Z","timestamp":1670962204000},"page":"103433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["The mutational impact of Illudin S on human cells"],"prefix":"10.1016","volume":"122","author":[{"given":"Lisa","family":"Casimir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e9lix","family":"Racine-Brassard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-\u00c9tienne","family":"Jacques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Mar\u00e9chal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dnarep.2022.103433_bib1","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1073\/pnas.38.8.655","article-title":"Antibiotic substances from basidiomycetes. VII. Clitocybe illudens*","volume":"38","author":"Anchel","year":"1952","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.dnarep.2022.103433_bib2","first-page":"3186","article-title":"Preclinical evaluation of Illudins as anticancer agents","volume":"47","author":"Kelner","year":"1987","journal-title":"Cancer Res."},{"key":"10.1016\/j.dnarep.2022.103433_bib3","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1093\/jnci\/82.19.1562","article-title":"Preclinical evaluation of Illudins as anticancer agents: basis for selective cytotoxicity","volume":"82","author":"Kelner","year":"1990","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"10.1016\/j.dnarep.2022.103433_bib4","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1021\/tx00018a013","article-title":"On the mechanism of toxicity of Illudins: the role of glutathione","volume":"3","author":"McMorris","year":"1990","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.dnarep.2022.103433_bib5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF00210787","article-title":"Efficacy of HMAF (MGI-114) in the MV522 metastatic lung carcinoma xenograft model nonresponsive to traditional anticancer agents","volume":"14","author":"Kelner","year":"1996","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.dnarep.2022.103433_bib6","first-page":"4936","article-title":"Efficacy of Acylfulvene Illudin analogues against a metastatic lung carcinoma MV522 xenograft nonresponsive to traditional anticancer agents: retention of activity against various mdr phenotypes and unusual cytotoxicity against ERCC2 and ERCC3 DNA helicas","volume":"55","author":"Kelner","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/j.dnarep.2022.103433_bib7","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1021\/np960450y","article-title":"Hydroxymethyl)acylfulvene: an Illudin derivative with superior antitumor properties","volume":"59","author":"McMorris","year":"1996","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.dnarep.2022.103433_bib8","first-page":"36","article-title":"Irofulven demonstrates clinical activity against metastatic hormone-refractory prostate cancer in a phase 2 single-agent trial","volume":"28","author":"Senzer","year":"2005","journal-title":"Am. J. Clin. Oncol. Cancer Clin. Trials"},{"key":"10.1016\/j.dnarep.2022.103433_bib9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1023\/A:1006433528750","article-title":"A phase II trial of 6-hydroxymethylacylfulvene (MGI-114, irofulven) in patients with advanced non-small cell cancer previously treated with chemotherapy","volume":"19","author":"Dowell","year":"2001","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.dnarep.2022.103433_bib10","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1023\/A:1016261918256","article-title":"A phase II study of Irofulven (MGI 114) in patients with stage IV melanoma","volume":"20","author":"Pierson","year":"2002","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.dnarep.2022.103433_bib11","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1111\/IGC.0b013e3181e8df36","article-title":"A phase II evaluation of Irofulven (IND#55804, NSC#683863) as second-line treatment of recurrent or persistent intermediately platinum-sensitive ovarian or primary peritoneal cancer: a Gynecologic Oncology Group trial","volume":"20","author":"Schilder","year":"2010","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.dnarep.2022.103433_bib12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ygyno.2005.09.036","article-title":"A phase II study of irofulven in women with recurrent and heavily pretreated ovarian cancer","volume":"101","author":"Seiden","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.dnarep.2022.103433_bib13","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.lungcan.2004.02.017","article-title":"A phase II trial of 6-hydroxymethylacylfulvene (MGI-114, irofulven) in patients with relapsed or refractory non-small cell lung cancer","volume":"45","author":"Sherman","year":"2004","journal-title":"Lung Cancer"},{"key":"10.1016\/j.dnarep.2022.103433_bib14","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00280-006-0270-1","article-title":"Irofulven as first line therapy in recurrent or metastatic gastric cancer: a phase II multicenter study by the Cancer Therapeutics Research Group (CTRG)","volume":"59","author":"Yeo","year":"2007","journal-title":"Cancer Chemother. Pharm."},{"key":"10.1016\/j.dnarep.2022.103433_bib15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.18632\/oncotarget.27943","article-title":"The acylfulvene alkylating agent, LP-184, retains nanomolar potency in non-small cell lung cancer carrying otherwise therapy-refractory mutations","volume":"12","author":"Kulkarni","year":"2021","journal-title":"Oncotarget"},{"key":"10.1016\/j.dnarep.2022.103433_bib16","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1021\/ja0665951","article-title":"Depurinating acylfulvene-DNA adducts: characterizing cellular chemical reactions of a selective antitumor agent","volume":"129","author":"Gong","year":"2007","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.dnarep.2022.103433_bib17","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1021\/tx300430r","article-title":"Quantification of acylfulvene- and Illudin S-DNA adducts in cells with variable bioactivation capacities","volume":"26","author":"Pietsch","year":"2013","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.dnarep.2022.103433_bib18","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cell.2020.05.040","article-title":"A genetic map of the response to DNA damage in human cells","volume":"182","author":"Olivieri","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.dnarep.2022.103433_bib19","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s41556-021-00688-9","article-title":"ELOF1 is a transcription-coupled DNA repair factor that directs RNA polymerase II ubiquitylation","volume":"23","author":"van der Weegen","year":"2021","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.dnarep.2022.103433_bib20","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1039\/b904720d","article-title":"Profiling patterns of glutathione reductase inhibition by the natural product Illudin S and its acylfulvene analogues","volume":"5","author":"Liu","year":"2009","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.dnarep.2022.103433_bib21","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1021\/tx2000152","article-title":"Susceptibility of the antioxidant selenoenyzmes thioredoxin reductase and glutathione peroxidase to alkylation-mediated inhibition by anticancer acylfulvenes","volume":"24","author":"Liu","year":"2011","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.dnarep.2022.103433_bib22","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0027-5107(89)90182-6","article-title":"Mutagenicity of ptaquiloside, the carcinogen in bracken, and its related illudane-type sesquiterpenes. II. Chromosomal aberration tests with cultured mammalian cells","volume":"215","author":"Matsuoka","year":"1989","journal-title":"Mutat. Res. - Fundam. Mol. Mech. Mutagen"},{"key":"10.1016\/j.dnarep.2022.103433_bib23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00204-013-1097-2","article-title":"Sulfotransferase-independent genotoxicity of Illudin S and its acylfulvene derivatives in bacterial and mammalian cells","volume":"88","author":"Glatt","year":"2014","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.dnarep.2022.103433_bib24","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0006-2952(94)90113-9","article-title":"Characterization of Illudin S sensitivity in DNA repair-deficient Chinese hamster cells","volume":"48","author":"Kelner","year":"1994","journal-title":"Biochem. Pharm."},{"key":"10.1016\/j.dnarep.2022.103433_bib25","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S1568-7864(02)00166-0","article-title":"Anti-tumour compounds Illudin S and Irofulven induce DNA lesions ignored by global repair and exclusively processed by transcription- and replication-coupled repair pathways","volume":"1","author":"Jaspers","year":"2002","journal-title":"DNA Repair"},{"key":"10.1016\/j.dnarep.2022.103433_bib26","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1016\/j.febslet.2011.04.044","article-title":"Roles of sequential ubiquitination of PCNA in DNA-damage tolerance","volume":"585","author":"Zhang","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.dnarep.2022.103433_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19102909","article-title":"Ubiquitylation at the fork: making and breaking chains to complete DNA replication","volume":"19","author":"Yates","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.dnarep.2022.103433_bib28","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1016\/j.febslet.2011.05.028","article-title":"Timing and spacing of ubiquitin-dependent DNA damage bypass","volume":"585","author":"Ulrich","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.dnarep.2022.103433_bib29","first-page":"1","article-title":"To skip or not to skip: choosing repriming to tolerate DNA damage","author":"Quinet","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.dnarep.2022.103433_bib30","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1158\/1078-0432.CCR-20-3322","article-title":"Targeting germline- and tumor-associated nucleotide excision repair defects in cancer","volume":"27","author":"Topka","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.dnarep.2022.103433_bib31","first-page":"2011","article-title":"Identification of a synthetic lethal relationship between nucleotide excision repair deficiency and irofulven sensitivity in urothelial cancer","author":"B\u00f6rcs\u00f6k","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.dnarep.2022.103433_bib32","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","article-title":"The repertoire of mutational signatures in human cancer","volume":"578","author":"Alexandrov","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.dnarep.2022.103433_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/science.abl9283","article-title":"Substitution mutational signatures in whole-genome\u2013sequenced cancers in the UK population","volume":"376","author":"Degasperi","year":"2022","journal-title":"Science (80-)"},{"key":"10.1016\/j.dnarep.2022.103433_bib34","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1038\/s41467-018-04052-8","article-title":"Validating the concept of mutational signatures with isogenic cell models","volume":"9","author":"Zou","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.dnarep.2022.103433_bib35","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1038\/s41467-018-04649-z","article-title":"Map of synthetic rescue interactions for the Fanconi anemia DNA repair pathway identifies USP48","volume":"9","author":"Velimezi","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.dnarep.2022.103433_bib36","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s002800050627","article-title":"Characterization of cellular accumulation and toxicity of Illudin S in sensitive and nonsensitive tumor cells","volume":"40","author":"Kelner","year":"1997","journal-title":"Cancer Chemother. Pharm."},{"key":"10.1016\/j.dnarep.2022.103433_bib37","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1101\/gr.230219.117","article-title":"In-depth characterization of the cisplatin mutational signature in human cell lines and in esophageal and liver tumors","volume":"28","author":"Boot","year":"2018","journal-title":"Genome Res."},{"key":"10.1016\/j.dnarep.2022.103433_bib38","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1101\/gr.255620.119","article-title":"Characterization of colibactin-associated mutational signature in an Asian oral squamous cell carcinoma and in other mucosal tumor types","volume":"30","author":"Boot","year":"2020","journal-title":"Genome Res."},{"key":"10.1016\/j.dnarep.2022.103433_bib39","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2019.03.001","article-title":"A compendium of mutational signatures of environmental agents","volume":"177","author":"Kucab","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.dnarep.2022.103433_bib40","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/s43018-021-00200-0","article-title":"A systematic CRISPR screen defines mutational mechanisms underpinning signatures caused by replication errors and endogenous DNA damage","volume":"2","author":"Zou","year":"2021","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.dnarep.2022.103433_bib41","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/ng.3557","article-title":"Somatic ERCC2 mutations are associated with a distinct genomic signature in urothelial tumors","volume":"48","author":"Kim","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.dnarep.2022.103433_bib42","doi-asserted-by":"crossref","first-page":"14784","DOI":"10.1016\/S0021-9258(18)68106-2","article-title":"Mutagenesis by transient misalignment","volume":"263","author":"Kunkel","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.dnarep.2022.103433_bib43","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1101\/SQB.1966.031.01.014","article-title":"Frameshift mutations and the genetic code","volume":"31","author":"Streisinger","year":"1966","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"10.1016\/j.dnarep.2022.103433_bib44","doi-asserted-by":"crossref","first-page":"5024","DOI":"10.1093\/nar\/gkt179","article-title":"Human polymerase kappa uses a template-slippage deletion mechanism, but can realign the slipped strands to favour base substitution mutations over deletions","volume":"41","author":"Mukherjee","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.dnarep.2022.103433_bib45","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1073\/pnas.1618555114","article-title":"Hypermutation signature reveals a slippage and realignment model of translesion synthesis by Rev3 polymerase in cisplatin-treated yeast","volume":"114","author":"Segovia","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.dnarep.2022.103433_bib46","doi-asserted-by":"crossref","unstructured":"M.F.G. Stevens, Temozolomide, in: Cancer Drug Des. Discov., 2014. doi: 10.1016\/b978-0-12-396521-9.00005-x.","DOI":"10.1016\/B978-0-12-396521-9.00005-X"},{"key":"10.1016\/j.dnarep.2022.103433_bib47","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.dnarep.2022.103433_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.3006086","article-title":"Genome-wide mutational signatures of aristolochic acid and its application as a screening tool","volume":"5","author":"Poon","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.dnarep.2022.103433_bib49","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006200","article-title":"Mutational signature of aristolochic acid exposure as revealed by whole-exome sequencing","volume":"5","author":"Hoang","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.dnarep.2022.103433_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.dnarep.2021.103208","article-title":"Transcription-coupled repair and the transcriptional response to UV-irradiation","volume":"107","author":"Gaul","year":"2021","journal-title":"DNA Repair"},{"key":"10.1016\/j.dnarep.2022.103433_bib51","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/cr.2008.6","article-title":"Transcription-coupled nucleotide excision repair in mammalian cells: molecular mechanisms and biological effects","volume":"18","author":"Fousteri","year":"2008","journal-title":"Cell Res."},{"key":"10.1016\/j.dnarep.2022.103433_bib52","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrm3822","article-title":"Understanding nucleotide excision repair and its roles in cancer and ageing","volume":"15","author":"Marteijn","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.dnarep.2022.103433_bib53","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s43018-020-0027-5","article-title":"A practical framework and online tool for mutational signature analyses show intertissue variation and driver dependencies","volume":"1","author":"Degasperi","year":"2020","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.dnarep.2022.103433_bib54","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a012708","article-title":"Translesion DNA synthesis and mutagenesis in eukaryotes","volume":"5","author":"Sale","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.dnarep.2022.103433_bib55","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.dnarep.2018.08.016","article-title":"Eukaryotic translesion synthesis: choosing the right tool for the job","volume":"71","author":"Powers","year":"2018","journal-title":"DNA Repair (Amst. )"},{"key":"10.1016\/j.dnarep.2022.103433_bib56","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.celrep.2018.06.120","article-title":"Pol V-mediated translesion synthesis elicits localized untargeted mutagenesis during post-replicative gap repair","volume":"24","author":"Isogawa","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.dnarep.2022.103433_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1010051","article-title":"Characterisation of the spectrum and genetic dependence of collateral mutations induced by translesion DNA synthesis","volume":"18","author":"P\u00f3ti","year":"2022","journal-title":"PLoS Genet."},{"key":"10.1016\/j.dnarep.2022.103433_bib58","article-title":"Strand-resolved mutagenicity of DNA damage and repair","volume":"15","author":"Anderson","year":"2022","journal-title":"BioRxiv"},{"key":"10.1016\/j.dnarep.2022.103433_bib59","doi-asserted-by":"crossref","first-page":"gev073","DOI":"10.1093\/mutage\/gev073","article-title":"The genome as a record of environmental exposure","volume":"30","author":"Nik-Zainal","year":"2015","journal-title":"Mutagenesis"},{"key":"10.1016\/j.dnarep.2022.103433_bib60","article-title":"BRCA1 deficiency specific base substitution mutagenesis is dependent on translesion synthesis and regulated by 53BP1","volume":"13","author":"Chen","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.dnarep.2022.103433_bib61","article-title":"Intrinsic base substitution patterns in diverse species reveal links to cancer and metabolism","author":"Gelova","year":"2020","journal-title":"Biorxiv"},{"key":"10.1016\/j.dnarep.2022.103433_bib62","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-022-04972-y","article-title":"Mechanisms of APOBEC3 mutagenesis in human cancer cells","volume":"607","author":"Petljak","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.dnarep.2022.103433_bib63","doi-asserted-by":"crossref","first-page":"eabn3815","DOI":"10.1126\/sciadv.abn3815","article-title":"Concordance of hydrogen peroxide-induced 8-oxo-guanine patterns with two cancer mutation signatures of upper GI tract tumors","volume":"8","author":"Jin","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.dnarep.2022.103433_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1073\/pnas.2007898118","article-title":"Defects in 8-oxo-guanine repair pathway cause high frequency of C\u2009>\u2009A substitutions in neuroblastoma","volume":"118","author":"van den Boogaard","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.dnarep.2022.103433_bib65","doi-asserted-by":"crossref","first-page":"39678","DOI":"10.1074\/jbc.M005309200","article-title":"Fidelity and processivity of DNA synthesis by DNA polymerase \u03ba, the product of the human DINB1 gene","volume":"275","author":"Ohashi","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.dnarep.2022.103433_bib66","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-15912-7","article-title":"Mutational signatures are jointly shaped by DNA damage and repair","volume":"11","author":"Volkova","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.dnarep.2022.103433_bib67","doi-asserted-by":"crossref","first-page":"12172","DOI":"10.1073\/pnas.1706592114","article-title":"Mechanism of RNA polymerase II stalling by DNA alkylation","volume":"114","author":"Malvezzi","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.dnarep.2022.103433_bib68","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/chem.201604289","article-title":"Minor groove 3-deaza-adenosine analogues: synthesis and bypass in translesion DNA synthesis","volume":"23","author":"Malvezzi","year":"2017","journal-title":"Chem. - A Eur. J."},{"key":"10.1016\/j.dnarep.2022.103433_bib69","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.cell.2019.05.028","article-title":"A small molecule targeting mutagenic translesion synthesis improves chemotherapy","volume":"178","author":"Wojtaszek","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.dnarep.2022.103433_bib70","doi-asserted-by":"crossref","first-page":"R100","DOI":"10.1186\/gb-2006-7-10-r100","article-title":"CellProfiler: image analysis software for identifying and quantifying cell phenotypes","volume":"7","author":"Carpenter","year":"2006","journal-title":"Genome Biol."},{"key":"10.1016\/j.dnarep.2022.103433_bib71","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.dnarep.2022.103433_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/gigascience\/giz037","article-title":"GenPipes: an open-source framework for distributed and scalable genomic analyses","volume":"8","author":"Bourgey","year":"2019","journal-title":"Gigascience"},{"key":"10.1016\/j.dnarep.2022.103433_bib73","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ng.806","article-title":"A framework for variation discovery and genotyping using next-generation DNA sequencing data","volume":"43","author":"Depristo","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.dnarep.2022.103433_bib74","first-page":"1","article-title":"Aligning sequence reads, clone sequences and assembly contigs with","volume":"00","author":"Li","year":"2013","journal-title":"BWA-MEM"},{"key":"10.1016\/j.dnarep.2022.103433_bib75","unstructured":"G.A. Van der Auwera, B.D. O\u2019Connor, Genomics in the Cloud: Using Docker, GATK, and WDL in Terra, O\u2019Reilly Media, 2020."},{"key":"10.1016\/j.dnarep.2022.103433_bib76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12864-022-08357-3","article-title":"MutationalPatterns: the one stop shop for the analysis of mutational processes","volume":"23","author":"Manders","year":"2022","journal-title":"BMC Genom."},{"key":"10.1016\/j.dnarep.2022.103433_bib77","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1080\/15548627.2018.1509608","article-title":"Transcriptional and epigenetic profiling of nutrient-deprived cells to identify novel regulators of autophagy","volume":"15","author":"Peeters","year":"2019","journal-title":"Autophagy"},{"key":"10.1016\/j.dnarep.2022.103433_bib78","article-title":"Archive for functional genomics data sets \u2013 update","volume":"41","author":"Barrett","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.dnarep.2022.103433_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13059-021-02533-6","article-title":"recount3: summaries and queries for large-scale RNA-seq expression and splicing","volume":"22","author":"Wilks","year":"2021","journal-title":"Genome Biol."},{"key":"10.1016\/j.dnarep.2022.103433_bib80","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/nmeth.2646","article-title":"pLogo: a probabilistic approach to visualizing sequence motifs","volume":"10","author":"O\u2019Shea","year":"2013","journal-title":"Nat. Methods"},{"key":"10.1016\/j.dnarep.2022.103433_bib81","unstructured":"\u3008https:\/\/www.targetedonc.com\/view\/fda-grants-orphan-drug-designation-to-lp-184-for-malignant-gliomas\u3009."},{"key":"10.1016\/j.dnarep.2022.103433_bib82","unstructured":"\u3008https:\/\/www.prnewswire.com\/news-releases\/lantern-pharma-receives-rare-pediatric-disease-and-orpan-drug-designations-for-lp-184-for-the-treatment-of-atypical-teratoid-rhabdoid-tumor-atrt--an-aggressive-and-rapidly-growing-form-of-cancer-of-the-central-nervous-system-301466429.html\u3009."},{"key":"10.1016\/j.dnarep.2022.103433_bib83","unstructured":"\u3008https:\/\/www.sec.gov\/Archives\/edgar\/data\/1763950\/000121390022011579\/ea156639ex99-1_lantern.htm\u3009."}],"container-title":["DNA Repair"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568786422001665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568786422001665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:51:44Z","timestamp":1761598304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568786422001665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":83,"alternative-id":["S1568786422001665"],"URL":"https:\/\/doi.org\/10.1016\/j.dnarep.2022.103433","relation":{},"ISSN":["1568-7864"],"issn-type":[{"value":"1568-7864","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The mutational impact of Illudin S on human cells","name":"articletitle","label":"Article Title"},{"value":"DNA Repair","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dnarep.2022.103433","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103433"}}